cholestyramine resin has been researched along with nafenopin in 1 studies
| Studies (cholestyramine resin) | Trials (cholestyramine resin) | Recent Studies (post-2010) (cholestyramine resin) | Studies (nafenopin) | Trials (nafenopin) | Recent Studies (post-2010) (nafenopin) |
|---|---|---|---|---|---|
| 2,669 | 342 | 190 | 227 | 2 | 3 |
| Protein | Taxonomy | cholestyramine resin (IC50) | nafenopin (IC50) |
|---|---|---|---|
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | 0.8151 | |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | 3.7405 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fumagalli, R; Paoletti, R; Sirtori, C | 1 |
1 review(s) available for cholestyramine resin and nafenopin
| Article | Year |
|---|---|
Hypolipidemic drugs.
Topics: Aminosalicylic Acids; Androgens; Bile Acids and Salts; Butyrates; Cellulose; Cholestyramine Resin; Clofibrate; Contraceptives, Oral; Female; Gonadal Steroid Hormones; Halofenate; Humans; Hyperlipidemias; Hypolipidemic Agents; Intestinal Absorption; Lignin; Lipid Metabolism; Lipid Mobilization; Male; Nafenopin; Neomycin; Nicotinic Acids; Oxandrolone; Probucol; Progestins; Sitosterols; Sterols; Thyroxine; Triglycerides | 1973 |